Virtus Investment Advisers, Inc. Tarsus Pharmaceuticals, Inc. Transaction History
Virtus Investment Advisers, Inc.
- $286 Million
- Q2 2025
A detailed history of Virtus Investment Advisers, Inc. transactions in Tarsus Pharmaceuticals, Inc. stock. As of the latest transaction made, Virtus Investment Advisers, Inc. holds 10,852 shares of TARS stock, worth $772,011. This represents 0.15% of its overall portfolio holdings.
Number of Shares
10,852
Previous 7,025
54.48%
Holding current value
$772,011
Previous $360,000
21.94%
% of portfolio
0.15%
Previous 0.12%
Shares
2 transactions
Others Institutions Holding TARS
# of Institutions
216Shares Held
46.7MCall Options Held
7.8KPut Options Held
0-
Black Rock Inc. New York, NY3.27MShares$232 Million0.0% of portfolio
-
Rtw Investments, LP New York, NY3.11MShares$221 Million1.94% of portfolio
-
Paradigm Biocapital Advisors LP New York, NY2.98MShares$212 Million5.63% of portfolio
-
Jennison Associates LLC2.47MShares$176 Million0.06% of portfolio
-
Tang Capital Management LLC San Diego, CA2.45MShares$175 Million5.96% of portfolio
About Tarsus Pharmaceuticals, Inc.
- Ticker TARS
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 26,658,500
- Market Cap $1.9B
- Description
- Tarsus Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, focuses on the development and commercialization of novel therapeutic candidates for ophthalmic conditions. Its lead product candidate is TP-03, a novel therapeutic that is in Phase III for the treatment of blepharitis caused by the infestation of Demodex mites, as well as...